Published in Biomed Res Int on September 12, 2013
Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature. J Clin Transl Hepatol (2016) 0.81
Refractory hypoxemia caused by hepatopulmonary syndrome: a case report. J Med Case Rep (2014) 0.75
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med (2008) 4.71
Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol (2008) 2.78
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med (2000) 2.43
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J (2004) 2.40
Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol (1999) 2.16
Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol (2001) 1.89
Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol (1998) 1.80
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology (1997) 1.74
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology (2006) 1.66
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology (1990) 1.63
Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest (1993) 1.61
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology (2010) 1.60
Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicol Rev (2003) 1.59
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology (2008) 1.50
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med (2002) 1.34
Sorafenib: a clinical and pharmacologic review. Expert Opin Pharmacother (2010) 1.29
Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest (1999) 1.24
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med (2001) 1.23
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology (2008) 1.23
Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther (1992) 1.18
Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology (1993) 1.11
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther (2008) 1.09
Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology (2006) 1.05
Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol (1985) (2006) 1.05
Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol (1998) 1.01
Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev (2009) 1.00
Mycophenolate mofetil: An update. Drugs Today (Barc) (2009) 1.00
Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett (2002) 1.00
Pharmacokinetics of the garlic compound S-allylcysteine. Planta Med (1994) 1.00
Methylene blue for the treatment of septic shock. Pharmacotherapy (2010) 0.99
Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med (1996) 0.98
Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome. Food Chem Toxicol (2007) 0.97
Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr (2006) 0.97
Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96
Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries. Clin Exp Pharmacol Physiol (2002) 0.96
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases. Kidney Int (2006) 0.95
Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl (2008) 0.95
The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can J Gastroenterol (2010) 0.95
Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology (1997) 0.94
The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol (2012) 0.91
Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat (2001) 0.89
Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med (2008) 0.88
Inhaled iloprost for the control of pulmonary hypertension. Vasc Health Risk Manag (2009) 0.87
Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clin Sci (Lond) (2013) 0.87
Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis (2001) 0.87
TNF-α neutralization improves experimental hepatopulmonary syndrome in rats. Liver Int (2012) 0.87
Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome. World J Gastroenterol (2006) 0.86
Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer (2005) 0.86
Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J Nutr (2009) 0.86
Protective effect of nitric oxide on hepatopulmonary syndrome from ischemia-reperfusion injury. World J Gastroenterol (2012) 0.85
N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin Pharmacol Toxicol (2008) 0.85
Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration. J Vasc Interv Radiol (2012) 0.84
Reversal of hypoxemia by inhaled nitric oxide in children with severe hepatopulmonary syndrome, type 1, during and after liver transplantation. Transplantation (1998) 0.83
Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress. Vascul Pharmacol (2007) 0.83
Nitric oxide and prostaglandins mediate vasodilation to 5,6-EET in rabbit lung. Adv Exp Med Biol (1997) 0.83
Methylene blue in the hepatopulmonary syndrome. N Engl J Med (1994) 0.83
Pentoxifylline in hepatopulmonary syndrome. World J Gastroenterol (2012) 0.82
Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia. Eur J Gastroenterol Hepatol (2007) 0.82
Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial. Clin Gastroenterol Hepatol (2010) 0.81
Ancient remedies revisited: does Allium sativum (garlic) palliate the hepatopulmonary syndrome? J Clin Gastroenterol (1992) 0.81
Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells. Respir Physiol Neurobiol (2012) 0.80
Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev (2012) 0.80
The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respir Med (1999) 0.80
Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans. Dig Dis Sci (2011) 0.80
Effects of caffeic acid phenethyl ester (CAPE) on hepatopulmonary syndrome. Inflammation (2011) 0.79
Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts. Clin Exp Immunol (2003) 0.79
Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation. Hepatol Res (2010) 0.79
Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology (1997) 0.79
Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions. Can J Gastroenterol (2009) 0.78
Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. J Gastroenterol Hepatol (2009) 0.78
Prostacyclin therapy for pulmonary arterial hypertension: new directions. Semin Respir Crit Care Med (2005) 0.78
Methylene blue used as a bridge to liver transplantation postoperative recovery: a case report. Transplant Proc (2010) 0.77
A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production). J Hepatol (2012) 0.77
Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome. Intensive Care Med (2001) 0.77
Methylene blue inhibits angiogenesis in chick chorioallontoic membrane through a nitric oxide-independent mechanism. J Cell Mol Med (2006) 0.77
Pulmonary evaluation in pediatric liver transplant candidates. Indian J Pediatr (2010) 0.76
Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome. Respiration (2001) 0.76
Effects of methylene blue, pentoxyphylline and enoxaparin on postoperative adhesion formation and markers of angiogenesis in a rat uterine horn model. Clin Exp Obstet Gynecol (2012) 0.76
A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine. Neth J Med (2005) 0.76
The efficacy of pentoxifylline in the treatment of vascular dementia: a systematic review. Alzheimer Dis Assoc Disord (2003) 0.76
Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease: experimental study in rats with biliary cirrhosis. Chest (2001) 0.75
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization. Hepatology (2006) 2.05
Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol (2006) 2.04
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer (2010) 1.92
The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist (2010) 1.84
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol (2004) 1.82
Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma. Antivir Ther (2011) 1.65
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol (2012) 1.63
Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2010) 1.51
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut (2013) 1.46
Can "healthy" normal alanine aminotransferase levels identify the metabolically obese phenotype? Findings from the Korea national health and nutrition examination survey 2008-2010. Dig Dis Sci (2014) 1.43
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer (2008) 1.40
[In vitro culture of hepatitis C virus (HCV) using immortalized hepatocyte]. Korean J Gastroenterol (2008) 1.39
Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys (2010) 1.36
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett (2011) 1.33
HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med (2005) 1.20
Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci (2005) 1.18
Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients. Eur J Gastroenterol Hepatol (2011) 1.15
SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis (2010) 1.13
Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin. J Clin Virol (2011) 1.13
Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}. J Biol Chem (2010) 1.12
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. J Biol Chem (2010) 1.09
Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys (2008) 1.09
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (2009) 1.06
Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium. Cancer Lett (2011) 1.05
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opin Drug Saf (2012) 1.05
Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol (2004) 1.05
Monitoring the antiviral effect of alpha interferon on individual cells. J Virol (2007) 1.03
Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2012) 1.01
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids (2010) 1.00
Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas (2011) 0.98
Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma. Radiat Oncol (2013) 0.98
A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Cancer Chemother Pharmacol (2006) 0.97
Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol (2012) 0.97
Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol (2007) 0.96
Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol (2012) 0.95
Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. J Virol (2011) 0.95
Functional identification of the pro-apoptotic effector domain in human Sox4. Biochem Biophys Res Commun (2004) 0.95
Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol (2010) 0.94
A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma. Korean J Hepatol (2010) 0.94
High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis (2009) 0.92
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2013) 0.91
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma. Radiat Oncol (2013) 0.91
Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B. World J Gastroenterol (2012) 0.91
Long-term survival in a patient with ruptured hepatocellular carcinoma. Korean J Intern Med (2009) 0.91
Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma. Korean J Hepatol (2011) 0.91
[A case of acute hepatitis E with the travel history to an endemic area]. Korean J Gastroenterol (2004) 0.91
Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV. Gut Liver (2011) 0.89
Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol (2014) 0.89
Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci (2005) 0.89
Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection. Korean J Intern Med (2007) 0.89
Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol (2013) 0.89
Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis. Cancer Chemother Pharmacol (2009) 0.88
Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease. Clin Mol Hepatol (2013) 0.87
Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano (2010) 0.87
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2013) 0.87
Piperine, an LXRα antagonist, protects against hepatic steatosis and improves insulin signaling in mice fed a high-fat diet. Biochem Pharmacol (2012) 0.87
Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma. Korean J Intern Med (2003) 0.87
Amiodarone hepatotoxicity. Hepatology (2012) 0.87
[Efficacy of transarterial chemolipiodolization with or without 3-dimensional conformal radiotherapy for huge HCC with portal vein tumor thrombosis]. Korean J Hepatol (2007) 0.87
Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma. Radiat Oncol (2014) 0.87
Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period. J Korean Med Sci (2009) 0.86
Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes. J Microbiol (2008) 0.86
Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma. World J Gastroenterol (2012) 0.85
Supraumbilical subcutaneous fat necrosis after transcatheter arterial chemoembolization with drug-eluting beads: case report and review of the literature. Cardiovasc Intervent Radiol (2012) 0.85
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice. Clin Mol Hepatol (2013) 0.85
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Liver Transpl (2012) 0.85
Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression. J Med Virol (2011) 0.85
Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol (2013) 0.84
A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure. Cytotherapy (2013) 0.84
Trends of Gastrointestinal Diseases at a Single Institution in Korea over the Past Two Decades. Gut Liver (2009) 0.83
Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Biomaterials (2011) 0.83
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis. J Gastroenterol Hepatol (2005) 0.83
Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection. ACS Nano (2012) 0.83
Early virological response predicts outcome during extended lamivudine retreatment in patients with chronic hepatitis B who relapsed after initial HBeAg responses. J Gastroenterol Hepatol (2006) 0.82
Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease. Hepatology (2010) 0.82
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. PLoS One (2013) 0.82
Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication. J Gastroenterol Hepatol (2007) 0.82
[Durability of sustained virologic response in chronic hepatitis C: analysis of factors related to relapse after sustained virologic response with peginterferon plus ribavirin combination therapy]. Korean J Gastroenterol (2011) 0.82
Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study. Liver Int (2005) 0.82
Trousseau's syndrome in association with cholangiocarcinoma: positive tests for coagulation factors and anticardiolipin antibody. J Korean Med Sci (2006) 0.82
Hepatitis C virus core inhibits the Fas-mediated p38 mitogen activated kinase signaling pathway in hepatocytes. Mol Cells (2002) 0.81
Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes. Nutr Res (2012) 0.81
Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure. J Gastroenterol (2013) 0.81
[The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease]. Korean J Hepatol (2009) 0.81
Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma. Scand J Gastroenterol (2010) 0.80
[Prediction of hepatic fibrosis using serum hyaluronic acid in patients with chronic liver disease]. Korean J Gastroenterol (2003) 0.80
RPL36 as a prognostic marker in hepatocellular carcinoma. Pathol Int (2011) 0.79
Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Immunol Lett (2006) 0.79
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response. Korean J Hepatol (2009) 0.79
Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy. J Med Virol (2007) 0.79
Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection. Biomaterials (2011) 0.79
Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Liver Int (2008) 0.79
Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma. Exp Mol Med (2011) 0.78
Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells. J Agric Food Chem (2012) 0.78
Functional characterization of human oncoprotein gankyrin in Zebrafish. Exp Mol Med (2009) 0.78
Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization. Korean J Hepatol (2011) 0.78
Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis. Clin Gastroenterol Hepatol (2009) 0.78
Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation. J Med Virol (2008) 0.78
[A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection]. Korean J Hepatol (2008) 0.78